Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Pieper

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The American Journal of Managed Care|September 21, 2002
Understanding niacin formulationsJohn A Pieper
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 7, 2003
Overview of niacin formulations: differences in pharmacokinetics, efficacy, and safetyJohn A Pieper
Clinical Therapeutics|September 27, 2003
The role of clopidogrel in the management of acute coronary syndromesAnna M Wodlinger, John A Pieper
Pharmacotherapy|January 14, 2003
Low-molecular-weight heparin in transesophageal echocardiography-guided cardioversion of atrial fibrillationAnna M Wodlinger, John A Pieper
Cardiovascular Drugs and Therapy|July 5, 2003
Genetic polymorphisms in emerging cardiovascular risk factors and response to statin therapyKimberly A Dornbrook-Lavender, John A Pieper
European Journal of Clinical Pharmacology|May 6, 2005
Twenty-four hour tolbutamide plasma concentration as a phenotypic measure of CYP2C9 activityCraig R Lee, Roy L Hawke, John A Pieper
Pharmacogenetics|April 3, 2002
Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human dataCraig R Lee, Joyce A Goldstein, John A Pieper
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 7, 2003
Niacin and the National Cholesterol Education Program Adult Treatment Panel III Guidelines: case studiesRobert L Talbert, John A Pieper, Matthew K Ito, et al.
The Annals of Pharmacotherapy|October 21, 2003
Primary prevention of coronary heart disease in the elderlyKimberly A Dornbrook-Lavender, John A Pieper, Mary T Roth
The Annals of Pharmacotherapy|November 25, 2003
Secondary prevention of coronary heart disease in the elderlyKimberly A Dornbrook-Lavender, Mary T Roth, John A Pieper
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The American Journal of Managed Care|September 21, 2002
Understanding niacin formulationsJohn A Pieper
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 7, 2003
Overview of niacin formulations: differences in pharmacokinetics, efficacy, and safetyJohn A Pieper
Clinical Therapeutics|September 27, 2003
The role of clopidogrel in the management of acute coronary syndromesAnna M Wodlinger, John A Pieper
Pharmacotherapy|January 14, 2003
Low-molecular-weight heparin in transesophageal echocardiography-guided cardioversion of atrial fibrillationAnna M Wodlinger, John A Pieper
Cardiovascular Drugs and Therapy|July 5, 2003
Genetic polymorphisms in emerging cardiovascular risk factors and response to statin therapyKimberly A Dornbrook-Lavender, John A Pieper
European Journal of Clinical Pharmacology|May 6, 2005
Twenty-four hour tolbutamide plasma concentration as a phenotypic measure of CYP2C9 activityCraig R Lee, Roy L Hawke, John A Pieper
Pharmacogenetics|April 3, 2002
Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human dataCraig R Lee, Joyce A Goldstein, John A Pieper
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 7, 2003
Niacin and the National Cholesterol Education Program Adult Treatment Panel III Guidelines: case studiesRobert L Talbert, John A Pieper, Matthew K Ito, et al.
The Annals of Pharmacotherapy|October 21, 2003
Primary prevention of coronary heart disease in the elderlyKimberly A Dornbrook-Lavender, John A Pieper, Mary T Roth
The Annals of Pharmacotherapy|November 25, 2003
Secondary prevention of coronary heart disease in the elderlyKimberly A Dornbrook-Lavender, Mary T Roth, John A Pieper
Pageof 2